Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease
Yongjia Hu, Zhouzhou Chen, Chengchen Xu, et al.
Nutrients (2022) Vol. 14, Iss. 23, pp. 5140-5140
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Inflammatory Bowel Diseases and Gut Microbiota
Yuri Haneishi, Yuma Furuya, Mayu Hasegawa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3817-3817
Open Access | Times Cited: 102
Gut microbiota as a key regulator of intestinal mucosal immunity
Jing Wang, Mei He, Ming Yang, et al.
Life Sciences (2024) Vol. 345, pp. 122612-122612
Closed Access | Times Cited: 16
Recent updates on correlation between reactive oxygen species and synbiotics for effective management of ulcerative colitis
Sumel Ashique, Neeraj Mishra, Ashish Garg, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 30
Urolithin A Alleviates Colitis in Mice by Improving Gut Microbiota Dysbiosis, Modulating Microbial Tryptophan Metabolism, and Triggering AhR Activation
Mingxia Ma, Yanxin Wang, Siqing Fan, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 20, pp. 7710-7722
Closed Access | Times Cited: 23
The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum
Jing Guo, Liping Li, Yue Cai, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Quzhou Aurantii Fructus Flavonoids Ameliorate Inflammatory Responses, Intestinal Barrier Dysfunction in DSS-Induced Colitis by Modulating PI3K/AKT Signaling Pathway and Gut Microbiome
Haiou Wang, Wenkang Huang, Xiaoya Pan, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1855-1874
Open Access | Times Cited: 1
L-Theanine prevents ulcerative colitis by regulating the CD4+ T cell immune response through the gut microbiota and its metabolites
Wei Xu, Ao-Xiang Liu, Zhihua Gong, et al.
The Journal of Nutritional Biochemistry (2025), pp. 109845-109845
Closed Access | Times Cited: 1
Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets
Yizhe Tie, Yongle Huang, Rirong Chen, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 20
Advancements in hydrogel-based drug delivery systems for the treatment of inflammatory bowel disease: a review
Ye Liu, Jinjian Huang, Sicheng Li, et al.
Biomaterials Science (2023) Vol. 12, Iss. 4, pp. 837-862
Closed Access | Times Cited: 20
Discovery of Bacteroides uniformis F18-22 as a Safe and Novel Probiotic Bacterium for the Treatment of Ulcerative Colitis from the Healthy Human Colon
Wei Dai, Jiaxue Zhang, Lu Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14669-14669
Open Access | Times Cited: 16
Integrative analysis of single-cell RNA-seq and gut microbiome metabarcoding data elucidates macrophage dysfunction in mice with DSS-induced ulcerative colitis
Dawon Hong, Hyo Keun Kim, Wonhee Yang, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 7
Neurobiological Implications of Chronic Stress and Metabolic Dysregulation in Inflammatory Bowel Diseases
Aleksandar Sič, Kiana Cvetkovic, Eshanika Manchanda, et al.
Diseases (2024) Vol. 12, Iss. 9, pp. 220-220
Open Access | Times Cited: 6
Huanglian Ganjiang Decoction alleviates DSS-induced colitis through suppressing inflammation and protecting intestinal barrier: from the perspective of disassembling prescriptions
Shihua Xu, Yequn Wu, Yi Wang, et al.
Journal of Ethnopharmacology (2025), pp. 119340-119340
Closed Access
Luteolin Alleviates Ulcerative Colitis in Mice by Modulating Gut Microbiota and Plasma Metabolism
Shuai Yang, Hongwei Duan, Zhenxing Yan, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 203-203
Open Access
Akkermansia muciniphila relieves inflammatory response in DSS-induced ulcerative colitis in mice through regulating macrophage polarization via SCFAs-SLC52A2/FFAR2 pathway
Lin Zhang, Junxi Wang, Ye Xu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Oral Tributyrin Treatment affects Short-Chain Fatty Acid Transport, Mucosal Health, and Microbiome in a Mouse Model of Inflammatory Diarrhea
Zhenghao Ye, Archana Kini, Qinghai Tan, et al.
The Journal of Nutritional Biochemistry (2025), pp. 109847-109847
Closed Access
The role of urinary microbiota in primary and recurrent bladder cancer: insights from a propensity score matching study
Zhuping Sheng, Jinshan Xu, Maoyu Wang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Diverse Physiological Roles of Kynurenine Pathway Metabolites: Updated Implications for Health and Disease
Yuechang Wang, Yonggang Zhang, Wei Wang, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 210-210
Open Access
CGA protects against experimental colitis by modulating host purine metabolism through the gut microbiota
Xiaolin Ye, Xueying An, Tianzhuo Zhang, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114547-114547
Closed Access
Qing-Re-Hua-Shi Decoction ameliorates DSS-induced colitis by modulating multiple signaling pathways and remodeling the gut microbiota and metabolite profile
Wei Chen, Xu Lin, Long Wang, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
NUDT1 aggravates intestinal epithelial barrier injury through oxidative stress in ulcerative colitis
Guiyuan Jin, Xizhuang Gao, Fengxian Dai, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114634-114634
Closed Access
Pretreatment with Bifidobacterium longum BAA2573 ameliorates dextran sulfate sodium (DSS)-induced colitis by modulating gut microbiota
Qiong Lin, Wu-Juan Hao, Ren-Min Zhou, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 12
Electroacupuncture Reduces Inflammatory Bowel Disease in Obese Mice by Activating the Nrf2/HO-1 Signaling Pathways and Repairing the Intestinal Barrier
Yunhao Yang, Fang Pang, Min Zhou, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 435-452
Open Access | Times Cited: 4
The oral-gut microbiome axis in inflammatory bowel disease: from inside to insight
Aili Wang, Zihan Zhai, Yiyun Ding, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Enhancing Gut Microbiome and Metabolic Health in Mice Through Administration of Presumptive Probiotic Strain Lactiplantibacillus pentosus PE11
Ioanna Farmakioti, Electra Stylianopoulou, Nikistratos Siskos, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 442-442
Open Access
Page 1 - Next Page

Scroll to top